Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05592951 · ClinicalTrials.gov registry record · NA
Safety and Tolerability of a Novel Amino-acid Based Hydration Drink in Healthy Volunteers
A NA study of Safety and Tolerance, sponsored by University of Memphis.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05592951 is a NA study of Safety and Tolerance that has completed, run by University of Memphis. The registered enrollment target is 40 participants, below the 125-participant average among 10 other Safety trials with a reported enrollment target (68% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05592951, a NA study of Safety and Tolerance, has completed, sponsored by University of Memphis.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The nutrient composition of this product is similar to the existing Liquid IV "hydration multiplier" product already on the market but with the addition of amino acids. With such low quantities of amino acids, in particular as compared to the amounts consumed in normal diets, there is no reason to believe that the product would cause any adverse outcomes. However, since no research has been done on the safety of regular consumption of this product, this study will evaluate the safety of the product with regards to routing blood chemistries and other variables. Specifically, standard testing will be performed including a measurement of vital signs, comprehensive metabolic panel, hematology panel, urinalysis, and quantification of triiodothyronine, thyroxine, and thyroid stimulating hormone. A questionnaire will also be used to assess product tolerability.
Interventions
- DIETARY_SUPPLEMENT Crystal Light (once serving)
- DIETARY_SUPPLEMENT Liquid IV with amino acids (one serving)
- DIETARY_SUPPLEMENT Liquid IV with amino acids (two servings)
- DIETARY_SUPPLEMENT Liquid IV with amino acids (three servings)
Study Locations (1)
Tennessee
- Center for Nutraceutical and Dietary Supplement Research - Memphis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2022-09-30 |
| Est. Completion | 2023-07-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05592951
The ClinicalTrials.gov registry entry for NCT05592951 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 125-participant average among 10 other Safety trials with a reported enrollment target (68% lower). The listed sponsor is University of Memphis, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Safety appearing as the primary indexed condition, and to 4 interventions - of which Crystal Light (once serving) is the first listed.
NCT05592951 reports 1 study location spanning 1 distinct geographic area - top geographies include Tennessee.
Frequently Asked Questions
What is clinical trial NCT05592951 about?
NCT05592951 is a clinical study titled "Safety and Tolerability of a Novel Amino-acid Based Hydration Drink in Healthy Volunteers". The nutrient composition of this product is similar to the existing Liquid IV "hydration multiplier" product already on the market but with the addition of amino acids. With such low quantities of amino acids, in particular as compared to the amounts consumed in normal diets, there is no reason to b...
What is the current status of trial NCT05592951?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2022-09-30. Estimated completion is 2023-07-18.
What conditions does trial NCT05592951 study?
This clinical trial studies the following conditions: Safety, Tolerance.
What interventions are being tested in trial NCT05592951?
The interventions under investigation include: Crystal Light (once serving) (DIETARY_SUPPLEMENT), Liquid IV with amino acids (one serving) (DIETARY_SUPPLEMENT), Liquid IV with amino acids (two servings) (DIETARY_SUPPLEMENT), Liquid IV with amino acids (three servings) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05592951?
This trial is sponsored by University of Memphis, which has 35 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05592951 being conducted?
This trial has 1 study location across Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Safety
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Developing a Dyadic Shared Decision Making Tool About Firearm Storage
COMPLETED · NA
-
Curcumin and Retinal Study
RECRUITING · Phase 1
-
PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study
RECRUITING · Phase 3
-
Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination
RECRUITING · Phase 1
-
Prospective G7 Dual Mobility Total Hip PMCF
ACTIVE NOT RECRUITING
-
Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.